The current legislative push towards drug pricing reform in the US began in 2019, when Democrats gained control of the House of Representatives and made the issue a centerpiece of their legislative activities.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?